BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEE-P Information Resource Center - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://deepconnections.net/ta_lk
X-WR-CALDESC:Events for DEE-P Information Resource Center
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260630T163000
DTEND;TZID=America/New_York:20260630T173000
DTSTAMP:20260617T205333Z
CREATED:20260605T035639Z
LAST-MODIFIED:20260617T205333Z
UID:8103-1782837000-1782840600@deepconnections.net
SUMMARY:Understanding ASOs & Informed Consent
DESCRIPTION:Join DEEP and KCNT1 for an educational webinar exploring the fundamentals of ASO therapies and the critical role of informed consent in rare disease care. This session is designed for caregivers\, clinicians\, researchers\, and advocates seeking a clearer understanding of how ASOs work\, where they fit within today’s treatment landscape\, and how families can approach conversations about experimental and individualized therapies. \n\n\n\nIn addition to clinical expertise\, this webinar will feature lived experience perspectives from caregivers who have firsthand experience navigating ASO-related decisions. Parent panelists will share their personal journeys\, including how they learned about ASOs\, the questions they asked\, the challenges they faced\, and what they wish they had known along the way. \n\n\n\nKey Topics\n\n\n\n\nWhat are antisense oligonucleotide (ASO) therapies?\n\n\n\nHow do ASOs work\, and where do they fit in current treatment and research?\n\n\n\nUnderstanding the benefits\, risks\, limitations\, and unknowns of emerging therapies\n\n\n\nWhat informed consent means beyond signing a form\n\n\n\nQuestions families should consider asking when evaluating treatment options\n\n\n\nParent perspectives on navigating ASO-related decisions\n\n\n\nBalancing hope\, uncertainty\, and informed decision-making in rare disease care\n\n\n\n\nSpeakers\n\n\n\nOlivia Kim-McManus\, MDDr. Olivia Kim-McManus is a pediatric neurologist and epileptologist at Rady Children’s Hospital-San Diego and Assistant Professor of Neurosciences at the University of California San Diego. She specializes in rare genetic epilepsies and precision therapeutics\, with a particular focus on developing individualized treatments\, including antisense oligonucleotide (ASO) therapies\, for children with severe neurological disorders.
URL:https://deepconnections.net/ta_lk/event/understanding-asos-informed-consent/
ATTACH;FMTTYPE=image/png:https://deepconnections.net/wp-content/uploads/2026/06/ASO-Webinar-3.png
END:VEVENT
END:VCALENDAR